Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$984M |
| 2 |
State Street Utilities Select Sector SPDR ETF
XLU
|
+$406M |
| 3 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$363M |
| 4 |
Comcast
CMCSA
|
+$305M |
| 5 |
DuPont de Nemours
DD
|
+$229M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.98B |
| 2 |
Linde
LIN
|
+$1.14B |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$976M |
| 4 |
AGN
Allergan plc
AGN
|
+$735M |
| 5 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$469M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 9.7% |
| 2 | Financials | 4.92% |
| 3 | Consumer Discretionary | 4.46% |
| 4 | Healthcare | 4.33% |
| 5 | Communication Services | 4.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4801
iShares MSCI Switzerland ETF
EWL
$2.2B
| $56K | ﹤0.01% |
1,450
| – | – |
|
4802
CALL
Galicia Financial Group
GGAL
$8.01B
| $56K | ﹤0.01% |
5,800
-13,100
| -69% | -$112K |
|
4803
Mastech Digital
MHH
$94.8M
| $56K | ﹤0.01% |
+2,147
| New | +$38.1K |
|
|
MPX
4804
DELISTED
Marine Products Corp
MPX
| $56K | ﹤0.01% |
4,030
+1,547
| +62% | +$16.2K |
|
4805
CALL
Travel + Leisure Co
TNL
$4.74B
| $56K | ﹤0.01% |
2,000
-91,900
| -98% | -$2.49M |
|
4806
PUT
Tapestry
TPR
$31.3B
| $56K | ﹤0.01% |
4,200
-30,500
| -88% | -$433K |
|
|
TUP
4807
CALL
DELISTED
Tupperware Brands Corporation
TUP
| $56K | ﹤0.01% |
11,800
-10,500
| -47% | -$34.9K |
|
|
LOGC
4808
DELISTED
LogicBio Therapeutics, Inc. Common Stock
LOGC
| $56K | ﹤0.01% |
6,606
+3,877
| +142% | +$25.5K |
|
|
ICBK
4809
DELISTED
County Bancorp, Inc. Common Stock
ICBK
| $56K | ﹤0.01% |
+2,716
| New | +$55.4K |
|
4810
PUT
ATI
ATI
$27B
| $55K | ﹤0.01% |
5,400
-1,200
| -18% | -$10.4K |
|
|
DCH
4811
CALL
Dauch Corp
DCH
$1.39B
| $55K | ﹤0.01% |
7,200
-29,200
| -80% | -$169K |
|
4812
PUT
Core Laboratories
CLB
$506M
| $55K | ﹤0.01% |
2,700
-25,200
| -90% | -$452K |
|
4813
Plumas Bancorp
PLBC
$429M
| $55K | ﹤0.01% |
+2,539
| New | +$49.2K |
|
4814
PUT
Vanguard FTSE Europe ETF
VGK
$31B
| $55K | ﹤0.01% |
1,100
-20,500
| -95% | -$967K |
|
4815
Xeris Biopharma Holdings
XERS
$1.39B
| $55K | ﹤0.01% |
20,578
+9,174
| +80% | +$31.9K |
|
|
MNDT
4816
CALL
DELISTED
Mandiant, Inc. Common Stock
MNDT
| $55K | ﹤0.01% |
4,500
-153,100
| -97% | -$1.78M |
|
4817
Chemung Financial Corp
CHMG
$402M
| $54K | ﹤0.01% |
1,988
+791
| +66% | +$20.9K |
|
4818
CALL
Canadian Imperial Bank of Commerce
CM
$109B
| $54K | ﹤0.01% |
1,600
-3,400
| -68% | -$106K |
|
4819
CALL
Darling Ingredients
DAR
$9.49B
| $54K | ﹤0.01% |
2,200
-4,700
| -68% | -$102K |
|
4820
Evolution Petroleum
EPM
$128M
| $54K | ﹤0.01% |
19,265
+7,954
| +70% | +$21.3K |
|
4821
Gaia
GAIA
$48.4M
| $54K | ﹤0.01% |
6,501
+3,004
| +86% | +$26.1K |
|
4822
Genie Energy
GNE
$372M
| $54K | ﹤0.01% |
7,281
+2,567
| +54% | +$20.1K |
|
4823
CALL
IAMGOLD
IAG
$8.55B
| $54K | ﹤0.01% |
13,600
-23,900
| -64% | -$82.2K |
|
4824
Saga Communications
SGA
$60.5M
| $54K | ﹤0.01% |
+2,123
| New | +$55.9K |
|
4825
Titan International
TWI
$469M
| $54K | ﹤0.01% |
37,248
-4,304
| -10% | -$5.79K |
|
Similar funds
Barclays's Q2 2020 Portfolio in Review
As of Q2 2020, Barclays held 6,627 positions worth $129B, up 2.3% from $127B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Barclays withdrew a net $22.7B in Q2 2020, closing 960 positions and reducing 2,655 holdings. Its most notable exit was Allergan plc, an estimated $735M position sold in full.
By sector, the portfolio is most concentrated in Technology at 9.7% of assets, up from 8.3% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Barclays opened a new position in iShares MSCI ACWI ex US ETF worth $123M.
- Barclays's largest Q2 2020 buy was iShares MSCI ACWI ex US ETF: 2,853,067 shares worth $123M.
- Barclays added most to iShares iBoxx $ High Yield Corporate Bond ETF in Q2 2020, an estimated $984M increase.
- Barclays's biggest Q2 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.98B.
- Barclays fully exited Allergan plc in Q2 2020, selling an estimated $735M.
- Barclays's ten largest holdings make up 34% of its $129B portfolio in Q2 2020.
- Barclays opened 468 new positions and closed 960 in Q2 2020.
- Barclays's portfolio value rose 2.3% quarter-over-quarter to $129B.
Based on Barclays's 13F filing for Q2 2020, filed 12 Aug 2020.